Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome

American Journal of Cardiology

Volumn 106, Issue 8, 2010, Pages 1090-1094

  Kronish, Ian M ^a   Rieckmann, Nina ^a,b   Shimbo, Daichi ^c   Burg, Matthew ^c   Davidson, Karina W ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COMORBIDITY; DEPRESSION; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; FOLLOW UP; MEDICATION COMPLIANCE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; C-REACTIVE PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957753108     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.018     Document Type: Article

References (28)

1. M. Feldman, I. Jialal, S. Devaraj, and B. Cryer Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay J Am Coll Cardiol 37 2001 2036 2041
2. D. Feng, R.P. Tracy, I. Lipinska, J. Murillo, C. McKenna, and G.H. Tofler Effect of short-term aspirin use on C-reactive protein J Thromb Thrombolysis 9 2000 37 41
3. M. Fisher, M. Cushman, V. Knappertz, and G. Howard An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration Am Heart J 156 2008 106 111
4. I. Ikonomidis, F. Andreotti, E. Economou, C. Stefanadis, P. Toutouzas, and P. Nihoyannopoulos Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin Circulation 100 1999 793 798
5. S. Solheim, H. Arnesen, L. Eikvar, M. Hurlen, and I. Seljeflot Influence of aspirin on inflammatory markers in patients after acute myocardial infarction Am J Cardiol 92 2003 843 845 (Pubitemid 37163584)
6. M. Woodward, G.D. Lowe, L.M. Francis, A. Rumley, and S.M. Cobbe A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial J Thromb Haemost 2 2004 1934 1940
7. I.M. Kronish, N. Rieckmann, E.A. Halm, D. Shimbo, D. Vorchheimer, D.C. Haas, and K.W. Davidson Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes J Gen Intern Med 21 2006 1178 1183
8. C.P. Cannon, A. Battler, R.G. Brindis, J.L. Cox, S.G. Ellis, N.R. Every, J.T. Flaherty, R.A. Harrington, H.M. Krumholz, M.L. Simoons, F.J. Van De Werf, W.S. Weintraub, K.R. Mitchell, S.L. Morrisson, R.G. Brindis, H.V. Anderson, D.S. Cannom, W.R. Chitwood, J.E. Cigarroa, R.L. Collins-Nakai, S.G. Ellis, R.J. Gibbons, F.L. Grover, P.A. Heidenreich, B.K. Khandheria, S.B. Knoebel, H.L. Krumholz, D.J. Malenka, D.B. Mark, C.R. McKay, E.R. Passamani, M.J. Radford, R.N. Riner, J.B. Schwartz, R.E. Shaw, R.J. Shemin, D.B. Van Fossen, E.D. Verrier, M.W. Watkins, D.R. Phoubandith, and T. Furnelli American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130
9. N. Rieckmann, W. Gerin, I.M. Kronish, M.M. Burg, W.F. Chaplin, G. Kong, F. Lesperance, and K.W. Davidson Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study J Am Coll Cardiol 48 2006 2218 2222
10. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
11. J.J. Strik, A. Honig, R. Lousberg, and J. Denollet Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction Psychosomatics 42 2001 423 428
12. D.E. Morisky, L.W. Green, and D.M. Levine Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 24 1986 67 74
13. R.P. Stowe, M.K. Peek, M.P. Cutchin, and J.S. Goodwin Plasma cytokine levels in a population-Based Study: relation to age and ethnicity J Gerontol A Biol Sci Med Sci 65 2009 429 433
14. R. Ruckerl, A. Peters, N. Khuseyinova, M. Andreani, W. Koenig, C. Meisinger, K. Dimakopoulou, J. Sunyer, T. Lanki, F. Nyberg, and A. Schneider Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors Clin Chem 55 2009 322 335
15. L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, and P.K. Whelton Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States Ann Intern Med 138 2003 891 897
16. G.E. Miller, C.A. Stetler, R.M. Carney, K.E. Freedland, and W.A. Banks Clinical depression and inflammatory risk markers for coronary heart disease Am J Cardiol 90 2002 1279 1283
17. D. Shimbo, N. Rieckmann, R. Paulino, and K.W. Davidson Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome Heart 92 2006 1316 1318
18. T. Cyrus, S. Sung, L. Zhao, C.D. Funk, S. Tang, and D. Pratico Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice Circulation 106 2002 1282 1287
19. D.N. Muller, V. Heissmeyer, R. Dechend, F. Hampich, J.K. Park, A. Fiebeler, E. Shagdarsuren, J. Theuer, M. Elger, B. Pilz, V. Breu, K. Schroer, D. Ganten, R. Dietz, H. Haller, C. Scheidereit, and F.C. Luft Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage FASEB J 15 2001 1822 1824
20. D.F. Kong, V. Hasselblad, D.E. Kandzari, L.K. Newby, and R.M. Califf Seeking the optimal aspirin dose in acute coronary syndromes Am J Cardiol 90 2002 622 625
21. C. Chrysohoou, D.B. Panagiotakos, C. Pitsavos, U.N. Das, and C. Stefanadis Adherence to the Mediterranean Ridge diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study J Am Coll Cardiol 44 2004 152 158
22. J. Yeaw, J.S. Benner, J.G. Walt, S. Sian, and D.B. Smith Comparing adherence and persistence across 6 chronic medication classes J Manag Care Pharm 15 2009 728 740
23. J.P. van Melle, P. de Jonge, T.A. Spijkerman, J.G. Tijssen, J. Ormel, D.J. van Veldhuisen, R.H. van den Brink, and M.P. van den Berg Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis Psychosom Med 66 2004 814 822
24. F. Lesperance, N. Frasure-Smith, M. Juneau, and P. Theroux Depression and 1-year prognosis in unstable angina Arch Intern Med 160 2000 1354 1360
25. R.M. Carney, K.E. Freedland, G.E. Miller, and A.S. Jaffe Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms J Psychosom Res 53 2002 897 902
26. H.S. Lett, J.A. Blumenthal, M.A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M.F. Newman Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment Psychosom Med 66 2004 305 315
27. K.A. Eagle, E. Kline-Rogers, S.G. Goodman, E.P. Gurfinkel, A. Avezum, M.D. Flather, C.B. Granger, S. Erickson, K. White, and P.G. Steg Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 2004 73 81
28. P.M. Ho, D.J. Magid, S.M. Shetterly, K.L. Olson, T.M. Maddox, P.N. Peterson, F.A. Masoudi, and J.S. Rumsfeld Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 2008 772 779